Life science companies need to recognize data as a strategic asset instead of a byproduct of the IT system in Drug Development Process. DDi's Risk Management Solution TULA, has come up with oversight features in the updated version to overcome this challenge.
Data is the most strategic asset in Drug Development. Governance is the vessel that organizations can use to take the necessary steps in transforming ...
Webinar On Best practices on INTERACTIVE RESPONSE TECHNOLOGY (IRT) and Clinical Supplies Management.
Join #DDi's online #Webinar on #IRT and #Clinical #Supply Chain Best Practices by Kate Chapman Former Associate Director, #IRT Services, #Shire Pharma ...
Satisfied Users & 
Approved Press Releases
